

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 7.05780071 |
| 2 | blood coagulation, intrinsic pathway (GO:0007597) | 6.70503297 |
| 3 | low-density lipoprotein particle remodeling (GO:0034374) | 6.65610013 |
| 4 | adenosine receptor signaling pathway (GO:0001973) | 6.53574336 |
| 5 | negative regulation of norepinephrine secretion (GO:0010700) | 6.44985745 |
| 6 | regulation of cholesterol esterification (GO:0010872) | 6.12755619 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75702470 |
| 8 | polyketide metabolic process (GO:0030638) | 5.63163055 |
| 9 | doxorubicin metabolic process (GO:0044598) | 5.63163055 |
| 10 | daunorubicin metabolic process (GO:0044597) | 5.63163055 |
| 11 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.24281604 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 5.21369800 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.21369800 |
| 14 | negative regulation of platelet activation (GO:0010544) | 5.11418679 |
| 15 | plasma lipoprotein particle remodeling (GO:0034369) | 5.07555975 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 5.07555975 |
| 17 | macromolecular complex remodeling (GO:0034367) | 5.07555975 |
| 18 | negative regulation of catecholamine secretion (GO:0033604) | 4.97150789 |
| 19 | regulation of platelet activation (GO:0010543) | 4.90224639 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.84641239 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 4.84641239 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 4.81920275 |
| 23 | negative regulation of heart rate (GO:0010459) | 4.81410867 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.79268280 |
| 25 | thrombin receptor signaling pathway (GO:0070493) | 4.76688281 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.70839614 |
| 27 | reverse cholesterol transport (GO:0043691) | 4.69028078 |
| 28 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.62585516 |
| 29 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.53666396 |
| 30 | platelet aggregation (GO:0070527) | 4.50583491 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 4.49590549 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 4.49590549 |
| 33 | tryptophan catabolic process (GO:0006569) | 4.49590549 |
| 34 | regulation of norepinephrine secretion (GO:0014061) | 4.35296240 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.24593120 |
| 36 | tryptophan metabolic process (GO:0006568) | 4.24553029 |
| 37 | plasma lipoprotein particle organization (GO:0071827) | 4.21521399 |
| 38 | relaxation of smooth muscle (GO:0044557) | 4.21157232 |
| 39 | phospholipid efflux (GO:0033700) | 4.17878145 |
| 40 | kynurenine metabolic process (GO:0070189) | 4.12723805 |
| 41 | lipoxygenase pathway (GO:0019372) | 4.12574805 |
| 42 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.12271057 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 4.09077455 |
| 44 | regulation of platelet aggregation (GO:0090330) | 4.06720003 |
| 45 | bile acid biosynthetic process (GO:0006699) | 4.05469971 |
| 46 | platelet degranulation (GO:0002576) | 3.97564799 |
| 47 | amine catabolic process (GO:0009310) | 3.95793722 |
| 48 | cellular biogenic amine catabolic process (GO:0042402) | 3.95793722 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 3.92978566 |
| 50 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.90915361 |
| 51 | plasma lipoprotein particle assembly (GO:0034377) | 3.89070170 |
| 52 | protein-lipid complex subunit organization (GO:0071825) | 3.87677521 |
| 53 | negative regulation of heart contraction (GO:0045822) | 3.85721604 |
| 54 | regulation of activation of Janus kinase activity (GO:0010533) | 3.85649652 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 3.83316305 |
| 56 | negative regulation of protein localization to cell surface (GO:2000009) | 3.82762496 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.75900057 |
| 58 | positive regulation of receptor recycling (GO:0001921) | 3.75451480 |
| 59 | cysteine metabolic process (GO:0006534) | 3.74422650 |
| 60 | negative regulation of appetite (GO:0032099) | 3.74201784 |
| 61 | negative regulation of response to food (GO:0032096) | 3.74201784 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.73219717 |
| 63 | protein carboxylation (GO:0018214) | 3.73219717 |
| 64 | glyoxylate metabolic process (GO:0046487) | 3.72863001 |
| 65 | regulation of lipoprotein metabolic process (GO:0050746) | 3.70671119 |
| 66 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.69500594 |
| 67 | serine family amino acid catabolic process (GO:0009071) | 3.67657012 |
| 68 | glutamate metabolic process (GO:0006536) | 3.67446131 |
| 69 | urea cycle (GO:0000050) | 3.63369901 |
| 70 | urea metabolic process (GO:0019627) | 3.63369901 |
| 71 | myelination in peripheral nervous system (GO:0022011) | 3.62550078 |
| 72 | peripheral nervous system axon ensheathment (GO:0032292) | 3.62550078 |
| 73 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.62254746 |
| 74 | regulation of fibrinolysis (GO:0051917) | 3.62140807 |
| 75 | cholesterol efflux (GO:0033344) | 3.59908211 |
| 76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59894560 |
| 77 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.58362923 |
| 78 | negative regulation of fibrinolysis (GO:0051918) | 3.57635839 |
| 79 | regulation of female receptivity (GO:0045924) | 3.56060226 |
| 80 | bile acid metabolic process (GO:0008206) | 3.54733294 |
| 81 | cerebellar granule cell differentiation (GO:0021707) | 3.53151689 |
| 82 | regulation of triglyceride catabolic process (GO:0010896) | 3.53092485 |
| 83 | beta-amyloid metabolic process (GO:0050435) | 3.50948019 |
| 84 | negative regulation of sterol transport (GO:0032372) | 3.50518099 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.50518099 |
| 86 | carnitine metabolic process (GO:0009437) | 3.49315144 |
| 87 | dopamine transport (GO:0015872) | 3.49036645 |
| 88 | regulation of protein activation cascade (GO:2000257) | 3.48986254 |
| 89 | linoleic acid metabolic process (GO:0043651) | 3.48314790 |
| 90 | drinking behavior (GO:0042756) | 3.48207474 |
| 91 | alpha-amino acid catabolic process (GO:1901606) | 3.46478475 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44968782 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 3.44322011 |
| 94 | endothelium development (GO:0003158) | 3.44081216 |
| 95 | behavioral response to cocaine (GO:0048148) | 3.42142691 |
| 96 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.41818568 |
| 97 | extracellular fibril organization (GO:0043206) | 3.40128116 |
| 98 | ethanol oxidation (GO:0006069) | 3.38268582 |
| 99 | angiogenesis involved in wound healing (GO:0060055) | 3.37298170 |
| 100 | complement activation, alternative pathway (GO:0006957) | 3.36370173 |
| 101 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.36118714 |
| 102 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.35406304 |
| 103 | aromatic amino acid family metabolic process (GO:0009072) | 3.34474115 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.34389183 |
| 105 | tyrosine metabolic process (GO:0006570) | 3.32979296 |
| 106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.31622378 |
| 107 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.29924023 |
| 108 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.29301513 |
| 109 | negative regulation of sodium ion transport (GO:0010766) | 3.28319759 |
| 110 | C4-dicarboxylate transport (GO:0015740) | 3.26025873 |
| 111 | cellular modified amino acid catabolic process (GO:0042219) | 3.25667601 |
| 112 | vesicle targeting (GO:0006903) | 3.25262694 |
| 113 | plasma lipoprotein particle clearance (GO:0034381) | 3.24157238 |
| 114 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.23693714 |
| 115 | nitrogen cycle metabolic process (GO:0071941) | 3.23198190 |
| 116 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.22448351 |
| 117 | tonic smooth muscle contraction (GO:0014820) | 3.21334528 |
| 118 | purine nucleotide transport (GO:0015865) | 3.20561219 |
| 119 | platelet activation (GO:0030168) | 3.19848036 |
| 120 | regulation of complement activation (GO:0030449) | 3.19643942 |
| 121 | negative regulation of muscle contraction (GO:0045932) | 3.19482598 |
| 122 | triglyceride homeostasis (GO:0070328) | 3.18520954 |
| 123 | acylglycerol homeostasis (GO:0055090) | 3.18520954 |
| 124 | cholesterol catabolic process (GO:0006707) | 3.17357691 |
| 125 | sterol catabolic process (GO:0016127) | 3.17357691 |
| 126 | negative regulation of amine transport (GO:0051953) | 3.17114577 |
| 127 | cellular amino acid catabolic process (GO:0009063) | 3.16791219 |
| 128 | coenzyme catabolic process (GO:0009109) | 3.15269602 |
| 129 | alanine transport (GO:0032328) | 3.14592738 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 3.14204921 |
| 131 | imidazole-containing compound metabolic process (GO:0052803) | 3.13991653 |
| 132 | gap junction assembly (GO:0016264) | 3.13066869 |
| 133 | cellular response to cholesterol (GO:0071397) | 3.12075750 |
| 134 | phospholipid homeostasis (GO:0055091) | 3.11613024 |
| 135 | female mating behavior (GO:0060180) | 3.11014909 |
| 136 | indolalkylamine metabolic process (GO:0006586) | 3.10634126 |
| 137 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.09938360 |
| 138 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.09518342 |
| 139 | neurotransmitter uptake (GO:0001504) | 3.08872949 |
| 140 | cGMP-mediated signaling (GO:0019934) | 3.07053089 |
| 141 | purine ribonucleotide transport (GO:0015868) | 3.06370835 |
| 142 | negative regulation of hemostasis (GO:1900047) | 3.04467318 |
| 143 | negative regulation of blood coagulation (GO:0030195) | 3.04467318 |
| 144 | drug catabolic process (GO:0042737) | 3.04229281 |
| 145 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.03964699 |
| 146 | cellular ketone body metabolic process (GO:0046950) | 3.03727850 |
| 147 | regulation of cholesterol efflux (GO:0010874) | 3.02228954 |
| 148 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.01407892 |
| 149 | regulation of sensory perception of pain (GO:0051930) | 3.01291496 |
| 150 | regulation of sensory perception (GO:0051931) | 3.01291496 |
| 151 | bile acid and bile salt transport (GO:0015721) | 3.01196255 |
| 152 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98784410 |
| 153 | positive regulation of steroid metabolic process (GO:0045940) | 2.96499120 |
| 154 | relaxation of muscle (GO:0090075) | 2.96189929 |
| 155 | cellular glucuronidation (GO:0052695) | 2.94253900 |
| 156 | opsonization (GO:0008228) | 2.94122927 |
| 157 | regulation of endothelial cell differentiation (GO:0045601) | 2.93847904 |
| 158 | homotypic cell-cell adhesion (GO:0034109) | 2.93443365 |
| 159 | positive regulation of hemostasis (GO:1900048) | 2.92683238 |
| 160 | positive regulation of blood coagulation (GO:0030194) | 2.92683238 |
| 161 | lipoprotein metabolic process (GO:0042157) | 2.91158078 |
| 162 | fibrinolysis (GO:0042730) | 2.90301208 |
| 163 | regulation of renal sodium excretion (GO:0035813) | 2.90202653 |
| 164 | lysine metabolic process (GO:0006553) | 2.90018237 |
| 165 | lysine catabolic process (GO:0006554) | 2.90018237 |
| 166 | arginine metabolic process (GO:0006525) | 2.87721127 |
| 167 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.87560253 |
| 168 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.86122844 |
| 169 | adenine nucleotide transport (GO:0051503) | 2.85026895 |
| 170 | negative regulation of lipase activity (GO:0060192) | 2.84334595 |
| 171 | fatty acid elongation (GO:0030497) | 2.83996588 |
| 172 | positive regulation of mast cell activation (GO:0033005) | 2.83693692 |
| 173 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.83691114 |
| 174 | amino acid import (GO:0043090) | 2.83677594 |
| 175 | regulation of integrin activation (GO:0033623) | 2.82101084 |
| 176 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.74253427 |
| 177 | negative regulation of blood circulation (GO:1903523) | 2.72095936 |
| 178 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.72011079 |
| 179 | purinergic receptor signaling pathway (GO:0035587) | 2.71416806 |
| 180 | regulation of response to food (GO:0032095) | 2.71194639 |
| 181 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.67597839 |
| 182 | polyamine biosynthetic process (GO:0006596) | 2.65175784 |
| 183 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.65054005 |
| 184 | negative regulation of coagulation (GO:0050819) | 2.62926810 |
| 185 | negative regulation of smooth muscle contraction (GO:0045986) | 2.62178505 |
| 186 | positive regulation of coagulation (GO:0050820) | 2.58085148 |
| 187 | cyclooxygenase pathway (GO:0019371) | 2.57304737 |
| 188 | fibril organization (GO:0097435) | 2.56573827 |
| 189 | male genitalia development (GO:0030539) | 2.56281982 |
| 190 | platelet formation (GO:0030220) | 2.56222840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.33868367 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.36329989 |
| 3 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.20383799 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.79375689 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60221026 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.52133534 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.28498097 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24217201 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.09827128 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.79670988 |
| 11 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46209922 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.39774315 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.27226232 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.17803874 |
| 15 | GATA1_19941826_ChIP-Seq_K562_Human | 2.06570107 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05100755 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.97502076 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92678318 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.90755959 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.89344182 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88810232 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83574040 |
| 23 | GATA2_19941826_ChIP-Seq_K562_Human | 1.80010331 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.76251829 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75021712 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74664471 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70569310 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70449508 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68364981 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67509514 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.65750564 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63627459 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57308513 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57230491 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54196778 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52708845 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51548319 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47212810 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43550192 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43550192 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43373356 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.42255016 |
| 43 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.41106458 |
| 44 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.41106458 |
| 45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.41106458 |
| 46 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.40476316 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39029905 |
| 48 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38822978 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37957006 |
| 50 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.37922930 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37744229 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36665397 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35339670 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35121465 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34032647 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31612173 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31439699 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30125632 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30084482 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.28419314 |
| 61 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28137902 |
| 62 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.27968816 |
| 63 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27216812 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26409001 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26068171 |
| 66 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.25654859 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24357356 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22193860 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20902358 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20855879 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.19099367 |
| 72 | * LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.18894095 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18454339 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16164553 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15509369 |
| 76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.15331593 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14295460 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14039333 |
| 79 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13809939 |
| 80 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13635470 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13159729 |
| 82 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.12340928 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10878548 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09760488 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09697344 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09572086 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09067014 |
| 88 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09067014 |
| 89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07970805 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06448959 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06380897 |
| 92 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05742573 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04650098 |
| 94 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04047088 |
| 95 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03913634 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02515974 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02433564 |
| 98 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01028483 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00850581 |
| 100 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00674360 |
| 101 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99718451 |
| 102 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.99435979 |
| 103 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.98943054 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98135418 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97109112 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96842704 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96275709 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96075974 |
| 109 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.95351544 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94787518 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92896174 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92776413 |
| 113 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92421170 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.92057566 |
| 115 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91913825 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91446579 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91396258 |
| 118 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90985653 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90803415 |
| 120 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89405659 |
| 121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88757948 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88568702 |
| 123 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.87413171 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.86865874 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86811810 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86520184 |
| 127 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86457207 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86106746 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86057143 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86049719 |
| 131 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84670546 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84455432 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83941945 |
| 134 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83471119 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82939607 |
| 136 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81754082 |
| 137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81196723 |
| 138 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81147515 |
| 139 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81019488 |
| 140 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80913245 |
| 141 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.80761306 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80534675 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80436125 |
| 144 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80269705 |
| 145 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80130178 |
| 146 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80118135 |
| 147 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79841451 |
| 148 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.79345066 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78777054 |
| 150 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.78065439 |
| 151 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77948723 |
| 152 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77385122 |
| 153 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76885243 |
| 154 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76737447 |
| 155 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.76636831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.35049410 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.66960484 |
| 3 | MP0005360_urolithiasis | 5.21836656 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.99586237 |
| 5 | MP0005365_abnormal_bile_salt | 4.69250824 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.66917170 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.30553542 |
| 8 | MP0003252_abnormal_bile_duct | 3.11116356 |
| 9 | MP0009840_abnormal_foam_cell | 3.00241817 |
| 10 | MP0005332_abnormal_amino_acid | 2.49616271 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.47912214 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.44355084 |
| 13 | MP0009697_abnormal_copulation | 2.37726708 |
| 14 | MP0009384_cardiac_valve_regurgitation | 2.35848279 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.34815633 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.32591605 |
| 17 | MP0005083_abnormal_biliary_tract | 2.28083335 |
| 18 | MP0004510_myositis | 2.21501748 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.13578532 |
| 20 | MP0005646_abnormal_pituitary_gland | 2.13093145 |
| 21 | MP0000566_synostosis | 2.11714459 |
| 22 | MP0003941_abnormal_skin_development | 2.02727902 |
| 23 | MP0003690_abnormal_glial_cell | 2.01345723 |
| 24 | MP0004885_abnormal_endolymph | 1.98049201 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.95876707 |
| 26 | MP0003878_abnormal_ear_physiology | 1.95876707 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.95094470 |
| 28 | MP0002254_reproductive_system_inflammat | 1.92087208 |
| 29 | MP0003195_calcinosis | 1.91970873 |
| 30 | MP0000343_altered_response_to | 1.88746858 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.86555705 |
| 32 | MP0003011_delayed_dark_adaptation | 1.84161966 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.81344614 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.80594220 |
| 35 | MP0003880_abnormal_central_pattern | 1.79568090 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.70990481 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.67513836 |
| 38 | MP0000579_abnormal_nail_morphology | 1.65026858 |
| 39 | MP0003136_yellow_coat_color | 1.58528957 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.57458707 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.57198335 |
| 42 | MP0005187_abnormal_penis_morphology | 1.55774414 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.55727092 |
| 44 | MP0005647_abnormal_sex_gland | 1.55117983 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.54101442 |
| 46 | MP0004130_abnormal_muscle_cell | 1.49454502 |
| 47 | MP0003279_aneurysm | 1.48551037 |
| 48 | MP0000609_abnormal_liver_physiology | 1.48065294 |
| 49 | MP0003868_abnormal_feces_composition | 1.47297724 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.47241977 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.43772546 |
| 52 | MP0001486_abnormal_startle_reflex | 1.41334423 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.39467098 |
| 54 | MP0004859_abnormal_synaptic_plasticity | 1.36656321 |
| 55 | MP0005023_abnormal_wound_healing | 1.36458881 |
| 56 | MP0006138_congestive_heart_failure | 1.35022848 |
| 57 | MP0005410_abnormal_fertilization | 1.34360334 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.33015087 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.32512072 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.31898969 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.31219731 |
| 62 | MP0003075_altered_response_to | 1.29654904 |
| 63 | MP0001919_abnormal_reproductive_system | 1.29443686 |
| 64 | MP0001756_abnormal_urination | 1.28970646 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.27092241 |
| 66 | MP0009764_decreased_sensitivity_to | 1.21663753 |
| 67 | MP0000383_abnormal_hair_follicle | 1.21585248 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.20205803 |
| 69 | MP0004272_abnormal_basement_membrane | 1.19146530 |
| 70 | MP0005171_absent_coat_pigmentation | 1.18322019 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17818723 |
| 72 | MP0003633_abnormal_nervous_system | 1.17149754 |
| 73 | MP0003724_increased_susceptibility_to | 1.17129100 |
| 74 | MP0001849_ear_inflammation | 1.15151448 |
| 75 | MP0002653_abnormal_ependyma_morphology | 1.14771833 |
| 76 | MP0002735_abnormal_chemical_nociception | 1.13720925 |
| 77 | MP0000249_abnormal_blood_vessel | 1.13320036 |
| 78 | MP0001970_abnormal_pain_threshold | 1.12869368 |
| 79 | MP0000604_amyloidosis | 1.12825632 |
| 80 | MP0001764_abnormal_homeostasis | 1.12800854 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.09153535 |
| 82 | MP0005670_abnormal_white_adipose | 1.07890115 |
| 83 | MP0004858_abnormal_nervous_system | 1.07254709 |
| 84 | MP0010030_abnormal_orbit_morphology | 1.06988723 |
| 85 | MP0006292_abnormal_olfactory_placode | 1.06756417 |
| 86 | MP0005501_abnormal_skin_physiology | 1.05130116 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.01813526 |
| 88 | MP0003329_amyloid_beta_deposits | 0.99689856 |
| 89 | MP0001851_eye_inflammation | 0.99263897 |
| 90 | MP0005620_abnormal_muscle_contractility | 0.95935260 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.95783380 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 0.95568172 |
| 93 | MP0000534_abnormal_ureter_morphology | 0.95372833 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.92931125 |
| 95 | MP0009053_abnormal_anal_canal | 0.91907414 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.91376482 |
| 97 | MP0008004_abnormal_stomach_pH | 0.90918592 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.89589080 |
| 99 | MP0003879_abnormal_hair_cell | 0.88888819 |
| 100 | MP0009745_abnormal_behavioral_response | 0.88647708 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.86662658 |
| 102 | MP0001984_abnormal_olfaction | 0.86559514 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.85350958 |
| 104 | MP0003942_abnormal_urinary_system | 0.80781208 |
| 105 | MP0001661_extended_life_span | 0.80281390 |
| 106 | MP0001853_heart_inflammation | 0.79908876 |
| 107 | MP0003631_nervous_system_phenotype | 0.79488402 |
| 108 | MP0002736_abnormal_nociception_after | 0.79252470 |
| 109 | MP0002128_abnormal_blood_circulation | 0.78900461 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.76806255 |
| 111 | MP0000428_abnormal_craniofacial_morphol | 0.76482433 |
| 112 | MP0002272_abnormal_nervous_system | 0.74700068 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.74692575 |
| 114 | MP0008569_lethality_at_weaning | 0.73937871 |
| 115 | MP0003303_peritoneal_inflammation | 0.73155176 |
| 116 | MP0002928_abnormal_bile_duct | 0.72947058 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.72756257 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 0.72437544 |
| 119 | MP0003828_pulmonary_edema | 0.71569752 |
| 120 | MP0003632_abnormal_nervous_system | 0.70839614 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.70558072 |
| 122 | MP0001663_abnormal_digestive_system | 0.70390808 |
| 123 | MP0005165_increased_susceptibility_to | 0.68561563 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.66705370 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.65984790 |
| 126 | MP0001968_abnormal_touch/_nociception | 0.65965244 |
| 127 | MP0000026_abnormal_inner_ear | 0.65476831 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.63599762 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.63175809 |
| 130 | MP0002067_abnormal_sensory_capabilities | 0.63065567 |
| 131 | MP0005385_cardiovascular_system_phenoty | 0.62733801 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.62733801 |
| 133 | MP0002064_seizures | 0.62303433 |
| 134 | MP0002938_white_spotting | 0.62202970 |
| 135 | MP0005423_abnormal_somatic_nervous | 0.62006608 |
| 136 | MP0004043_abnormal_pH_regulation | 0.61464294 |
| 137 | MP0004085_abnormal_heartbeat | 0.60676693 |
| 138 | MP0005166_decreased_susceptibility_to | 0.60536417 |
| 139 | MP0003705_abnormal_hypodermis_morpholog | 0.59736763 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.59216421 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.59003181 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.58630794 |
| 143 | MP0008874_decreased_physiological_sensi | 0.58212766 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.57949838 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.57289862 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.57207633 |
| 147 | MP0001664_abnormal_digestion | 0.56052422 |
| 148 | MP0005275_abnormal_skin_tensile | 0.55294020 |
| 149 | MP0006276_abnormal_autonomic_nervous | 0.55065519 |
| 150 | MP0001501_abnormal_sleep_pattern | 0.54936991 |
| 151 | MP0004924_abnormal_behavior | 0.54891737 |
| 152 | MP0005386_behavior/neurological_phenoty | 0.54891737 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.54736835 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.54721365 |
| 155 | MP0001542_abnormal_bone_strength | 0.54112685 |
| 156 | MP0009763_increased_sensitivity_to | 0.53743516 |
| 157 | MP0008872_abnormal_physiological_respon | 0.51840094 |
| 158 | MP0003635_abnormal_synaptic_transmissio | 0.51517093 |
| 159 | MP0003634_abnormal_glial_cell | 0.49537780 |
| 160 | MP0005451_abnormal_body_composition | 0.47484506 |
| 161 | MP0002063_abnormal_learning/memory/cond | 0.47307593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 9.75728848 |
| 2 | Increased mean platelet volume (HP:0011877) | 9.42882126 |
| 3 | Abnormal platelet volume (HP:0011876) | 8.56205139 |
| 4 | Purpura (HP:0000979) | 8.40352847 |
| 5 | Petechiae (HP:0000967) | 7.64651737 |
| 6 | Epistaxis (HP:0000421) | 6.41995652 |
| 7 | Deep venous thrombosis (HP:0002625) | 5.40055824 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.37675714 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.30457909 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.22718453 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 5.19612127 |
| 12 | Xanthomatosis (HP:0000991) | 5.18278802 |
| 13 | Abnormal platelet function (HP:0011869) | 4.44315819 |
| 14 | Impaired platelet aggregation (HP:0003540) | 4.44315819 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.18215592 |
| 16 | Hyperglycinemia (HP:0002154) | 4.05712773 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.01239099 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.97196748 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.94796198 |
| 20 | Joint hemorrhage (HP:0005261) | 3.87195174 |
| 21 | Conjunctival telangiectasia (HP:0000524) | 3.77401686 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.70859069 |
| 23 | Parakeratosis (HP:0001036) | 3.67227082 |
| 24 | Vascular calcification (HP:0004934) | 3.62869010 |
| 25 | Mitral stenosis (HP:0001718) | 3.56638601 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51387571 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.46066423 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.40996196 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40996196 |
| 30 | Abnormal pupillary function (HP:0007686) | 3.39938559 |
| 31 | Follicular hyperkeratosis (HP:0007502) | 3.36474771 |
| 32 | Abnormal auditory evoked potentials (HP:0006958) | 3.36399201 |
| 33 | Cardiovascular calcification (HP:0011915) | 3.35617098 |
| 34 | Hyperglycinuria (HP:0003108) | 3.34577604 |
| 35 | Hyperammonemia (HP:0001987) | 3.34351143 |
| 36 | Potter facies (HP:0002009) | 3.31721834 |
| 37 | Facial shape deformation (HP:0011334) | 3.31721834 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.29244570 |
| 39 | Acanthocytosis (HP:0001927) | 3.28941127 |
| 40 | Alopecia of scalp (HP:0002293) | 3.27969621 |
| 41 | Ketosis (HP:0001946) | 3.26468980 |
| 42 | Epidermoid cyst (HP:0200040) | 3.23952914 |
| 43 | Complement deficiency (HP:0004431) | 3.20239835 |
| 44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.13932345 |
| 45 | Split foot (HP:0001839) | 3.13859092 |
| 46 | Dyschromatopsia (HP:0007641) | 3.13244992 |
| 47 | Hypoplastic left heart (HP:0004383) | 3.09668550 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09346167 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.07537240 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03412966 |
| 51 | Upper limb muscle weakness (HP:0003484) | 3.01074558 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 3.00211290 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00074795 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.98997780 |
| 55 | Poikilocytosis (HP:0004447) | 2.96922928 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.89618179 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.89618179 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.89618179 |
| 59 | Fat malabsorption (HP:0002630) | 2.82287312 |
| 60 | Recurrent corneal erosions (HP:0000495) | 2.73870381 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.70954410 |
| 62 | Hemiparesis (HP:0001269) | 2.70408222 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.70105850 |
| 64 | Ketoacidosis (HP:0001993) | 2.69966963 |
| 65 | Abnormality of the axillary hair (HP:0100134) | 2.69913964 |
| 66 | Abnormality of secondary sexual hair (HP:0009888) | 2.69913964 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.69357803 |
| 68 | Hemiplegia (HP:0002301) | 2.65433678 |
| 69 | Paralysis (HP:0003470) | 2.63174607 |
| 70 | Paraparesis (HP:0002385) | 2.61882201 |
| 71 | Renal cortical cysts (HP:0000803) | 2.61024402 |
| 72 | Bruising susceptibility (HP:0000978) | 2.60887972 |
| 73 | Hyperventilation (HP:0002883) | 2.59020989 |
| 74 | Widely patent fontanelles and sutures (HP:0004492) | 2.55427207 |
| 75 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53126101 |
| 76 | Enlarged kidneys (HP:0000105) | 2.49988837 |
| 77 | Confusion (HP:0001289) | 2.49439578 |
| 78 | Hypoplastic heart (HP:0001961) | 2.48513702 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.41692175 |
| 80 | Abnormality of the intrinsic pathway (HP:0010989) | 2.39218672 |
| 81 | Tongue fasciculations (HP:0001308) | 2.35484734 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.32092292 |
| 83 | Hyperbilirubinemia (HP:0002904) | 2.28550924 |
| 84 | Absent hair (HP:0002298) | 2.27439670 |
| 85 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26071409 |
| 86 | Tetraparesis (HP:0002273) | 2.23287915 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 2.21666311 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.20444248 |
| 89 | Distal lower limb amyotrophy (HP:0008944) | 2.19339245 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18534189 |
| 91 | Gingival bleeding (HP:0000225) | 2.16155257 |
| 92 | Increased density of long bones (HP:0006392) | 2.16108685 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.15346085 |
| 94 | Myocardial infarction (HP:0001658) | 2.14218725 |
| 95 | Steatorrhea (HP:0002570) | 2.14067269 |
| 96 | Lower limb amyotrophy (HP:0007210) | 2.12723443 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 2.12299280 |
| 98 | Abnormality of serum amino acid levels (HP:0003112) | 2.11760055 |
| 99 | Metabolic acidosis (HP:0001942) | 2.10750935 |
| 100 | Abnormality of complement system (HP:0005339) | 2.10608881 |
| 101 | Abnormality of lateral ventricle (HP:0030047) | 2.10512176 |
| 102 | Decreased central vision (HP:0007663) | 2.10053176 |
| 103 | Insidious onset (HP:0003587) | 2.09505513 |
| 104 | Termporal pattern (HP:0011008) | 2.09505513 |
| 105 | Abnormality of the diencephalon (HP:0010662) | 2.07968877 |
| 106 | Hyperthyroidism (HP:0000836) | 2.07846996 |
| 107 | Spastic paraparesis (HP:0002313) | 2.01774374 |
| 108 | Spontaneous abortion (HP:0005268) | 2.00359801 |
| 109 | Menorrhagia (HP:0000132) | 10.0912590 |
| 110 | Myokymia (HP:0002411) | 1.98561492 |
| 111 | Bile duct proliferation (HP:0001408) | 1.97577006 |
| 112 | Abnormal biliary tract physiology (HP:0012439) | 1.97577006 |
| 113 | Back pain (HP:0003418) | 1.97242917 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.96744795 |
| 115 | Dry hair (HP:0011359) | 1.95694753 |
| 116 | Biliary tract neoplasm (HP:0100574) | 1.95399512 |
| 117 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95050764 |
| 118 | Muscle fibrillation (HP:0010546) | 1.94951879 |
| 119 | Esophageal varix (HP:0002040) | 1.94545008 |
| 120 | Clumsiness (HP:0002312) | 1.93955939 |
| 121 | Tinnitus (HP:0000360) | 1.93666582 |
| 122 | Hepatosplenomegaly (HP:0001433) | 1.92820486 |
| 123 | Status epilepticus (HP:0002133) | 1.92718518 |
| 124 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90755294 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88932490 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 1.88932490 |
| 127 | Aortic aneurysm (HP:0004942) | 1.86423659 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.86396066 |
| 129 | Mesangial abnormality (HP:0001966) | 1.84854076 |
| 130 | Amyloidosis (HP:0011034) | 1.84755151 |
| 131 | Rickets (HP:0002748) | 1.83405059 |
| 132 | Late onset (HP:0003584) | 1.82515644 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.81913982 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.81913982 |
| 135 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81680602 |
| 136 | Mixed hearing impairment (HP:0000410) | 1.81441497 |
| 137 | Abnormal eating behavior (HP:0100738) | 1.81282822 |
| 138 | Symptomatic seizures (HP:0011145) | 1.80946265 |
| 139 | Lethargy (HP:0001254) | 1.80890436 |
| 140 | Absent eyelashes (HP:0000561) | 1.80144521 |
| 141 | Abnormality of purine metabolism (HP:0004352) | 1.79540442 |
| 142 | Patent foramen ovale (HP:0001655) | 1.78035483 |
| 143 | Congenital, generalized hypertrichosis (HP:0004540) | 1.77286766 |
| 144 | Opisthotonus (HP:0002179) | 1.76947014 |
| 145 | Cerebral inclusion bodies (HP:0100314) | 1.76023729 |
| 146 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75295805 |
| 147 | Gout (HP:0001997) | 1.75283979 |
| 148 | Pseudobulbar signs (HP:0002200) | 1.74764601 |
| 149 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74452466 |
| 150 | Testicular neoplasm (HP:0010788) | 1.73416880 |
| 151 | Leiomyosarcoma (HP:0100243) | 1.72953754 |
| 152 | Uterine leiomyosarcoma (HP:0002891) | 1.72953754 |
| 153 | Atrioventricular block (HP:0001678) | 1.71498131 |
| 154 | Glomerulosclerosis (HP:0000096) | 1.70358390 |
| 155 | Hypoplasia of the iris (HP:0007676) | 1.68443987 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.68140708 |
| 157 | Muscle fiber splitting (HP:0003555) | 1.66879032 |
| 158 | Action tremor (HP:0002345) | 1.56907235 |
| 159 | Abnormal large intestine physiology (HP:0012700) | 1.56862187 |
| 160 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.55791780 |
| 161 | Gastrointestinal carcinoma (HP:0002672) | 1.55791780 |
| 162 | Glomerulonephritis (HP:0000099) | 1.54200055 |
| 163 | Neoplasm of the small intestine (HP:0100833) | 1.50262128 |
| 164 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.50196590 |
| 165 | Focal segmental glomerulosclerosis (HP:0000097) | 1.49555008 |
| 166 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.49547521 |
| 167 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.49265162 |
| 168 | Arthropathy (HP:0003040) | 1.48003251 |
| 169 | Nausea (HP:0002018) | 1.47169365 |
| 170 | Polyphagia (HP:0002591) | 1.47077521 |
| 171 | Nephritis (HP:0000123) | 1.44962503 |
| 172 | Concave nail (HP:0001598) | 1.44762491 |
| 173 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.44414883 |
| 174 | Joint swelling (HP:0001386) | 1.41941724 |
| 175 | Papillary thyroid carcinoma (HP:0002895) | 1.41279511 |
| 176 | Infertility (HP:0000789) | 1.38946602 |
| 177 | Stroke (HP:0001297) | 1.38434905 |
| 178 | Delayed epiphyseal ossification (HP:0002663) | 1.36136929 |
| 179 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.34031270 |
| 180 | Short middle phalanx of the 5th finger (HP:0004220) | 1.32211902 |
| 181 | Male infertility (HP:0003251) | 1.32191150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 5.15314934 |
| 2 | MST4 | 4.86577402 |
| 3 | BMX | 4.73380242 |
| 4 | SIK3 | 3.53911020 |
| 5 | PNCK | 3.23991423 |
| 6 | MUSK | 3.12971052 |
| 7 | EPHA4 | 2.89987202 |
| 8 | CASK | 2.85204560 |
| 9 | INSRR | 2.78167137 |
| 10 | LATS1 | 2.74569652 |
| 11 | BCKDK | 2.73021583 |
| 12 | TNIK | 2.62497339 |
| 13 | ZAK | 2.19041738 |
| 14 | MAPK12 | 2.18244842 |
| 15 | SIK2 | 2.18168000 |
| 16 | ILK | 2.12066526 |
| 17 | TEC | 2.11491787 |
| 18 | BTK | 2.08269985 |
| 19 | STK3 | 1.93415885 |
| 20 | GRK5 | 1.90512516 |
| 21 | SGK2 | 1.89872962 |
| 22 | ADRBK2 | 1.87976802 |
| 23 | MAP2K7 | 1.86547564 |
| 24 | MAPK7 | 1.86089727 |
| 25 | MAPKAPK3 | 1.85491723 |
| 26 | PTK2B | 1.79861918 |
| 27 | DAPK3 | 1.64847157 |
| 28 | EIF2AK1 | 1.58268030 |
| 29 | DAPK2 | 1.48855310 |
| 30 | MAPK11 | 1.46205642 |
| 31 | IRAK3 | 1.45531442 |
| 32 | LMTK2 | 1.43553947 |
| 33 | SGK3 | 1.39255031 |
| 34 | PHKG2 | 1.37535477 |
| 35 | PHKG1 | 1.37535477 |
| 36 | MAP2K4 | 1.35873550 |
| 37 | STK38L | 1.35652434 |
| 38 | NTRK3 | 1.33758688 |
| 39 | TNK2 | 1.33236857 |
| 40 | PINK1 | 1.31740202 |
| 41 | SGK494 | 1.27389098 |
| 42 | SGK223 | 1.27389098 |
| 43 | ERBB4 | 1.22454447 |
| 44 | ERBB2 | 1.20634234 |
| 45 | STK24 | 1.20120080 |
| 46 | PRKCG | 1.19877352 |
| 47 | RET | 1.18477712 |
| 48 | TAOK3 | 1.17858277 |
| 49 | BLK | 1.16461925 |
| 50 | DMPK | 1.16252558 |
| 51 | FGFR4 | 1.15479266 |
| 52 | NTRK2 | 1.15311101 |
| 53 | PLK2 | 1.15204285 |
| 54 | MAPK13 | 1.14745426 |
| 55 | DDR2 | 1.14495462 |
| 56 | BMPR2 | 1.12714093 |
| 57 | CAMK2B | 1.08864807 |
| 58 | PAK1 | 1.06859640 |
| 59 | FER | 1.05475371 |
| 60 | MAP3K12 | 1.04321503 |
| 61 | FRK | 1.04296338 |
| 62 | TXK | 1.00200679 |
| 63 | PRPF4B | 0.98124746 |
| 64 | TAOK2 | 0.97778698 |
| 65 | RIPK4 | 0.94958586 |
| 66 | CAMK1G | 0.93137170 |
| 67 | FLT3 | 0.89066752 |
| 68 | FGFR2 | 0.88398471 |
| 69 | NLK | 0.87984764 |
| 70 | MAP3K4 | 0.87694956 |
| 71 | PKN2 | 0.85759109 |
| 72 | PDGFRB | 0.84867956 |
| 73 | MAP3K14 | 0.83580713 |
| 74 | PRKD1 | 0.83196811 |
| 75 | ERN1 | 0.83028782 |
| 76 | FES | 0.82959862 |
| 77 | CAMKK2 | 0.82138699 |
| 78 | SYK | 0.79208043 |
| 79 | PRKCE | 0.78405227 |
| 80 | IGF1R | 0.77177767 |
| 81 | ZAP70 | 0.76646189 |
| 82 | DYRK2 | 0.75165450 |
| 83 | IRAK1 | 0.75123922 |
| 84 | PRKAA2 | 0.74832625 |
| 85 | PAK2 | 0.73686258 |
| 86 | SGK1 | 0.73513003 |
| 87 | MAPK4 | 0.72982555 |
| 88 | MAPKAPK5 | 0.72704495 |
| 89 | STK38 | 0.71552155 |
| 90 | MAP3K7 | 0.71415991 |
| 91 | YES1 | 0.71113461 |
| 92 | EPHA3 | 0.71040313 |
| 93 | LATS2 | 0.70365595 |
| 94 | ADRBK1 | 0.69316564 |
| 95 | MYLK | 0.69308245 |
| 96 | AKT3 | 0.66815206 |
| 97 | EPHB2 | 0.65960238 |
| 98 | HCK | 0.64705943 |
| 99 | MINK1 | 0.64643062 |
| 100 | CAMKK1 | 0.64462152 |
| 101 | PDGFRA | 0.64037245 |
| 102 | TLK1 | 0.63281866 |
| 103 | ROCK1 | 0.63174302 |
| 104 | PRKCZ | 0.62832186 |
| 105 | PIK3CG | 0.61576795 |
| 106 | MARK2 | 0.60960812 |
| 107 | MARK3 | 0.60766898 |
| 108 | NTRK1 | 0.59818651 |
| 109 | JAK3 | 0.57612668 |
| 110 | MAPK15 | 0.56321589 |
| 111 | NEK9 | 0.55476478 |
| 112 | GRK1 | 0.55218127 |
| 113 | MST1R | 0.55083685 |
| 114 | CAMK2D | 0.54921828 |
| 115 | CDC7 | 0.52882196 |
| 116 | CAMK4 | 0.52807380 |
| 117 | CAMK2A | 0.52802255 |
| 118 | TIE1 | 0.52571506 |
| 119 | FGR | 0.52126121 |
| 120 | CAMK2G | 0.51679273 |
| 121 | DAPK1 | 0.50994709 |
| 122 | PRKACG | 0.50799841 |
| 123 | BRSK2 | 0.48999088 |
| 124 | CAMK1 | 0.48508459 |
| 125 | PRKCH | 0.48218674 |
| 126 | MKNK2 | 0.47138373 |
| 127 | PRKCQ | 0.46186132 |
| 128 | ARAF | 0.46125457 |
| 129 | PRKAA1 | 0.45706861 |
| 130 | RIPK1 | 0.45411747 |
| 131 | MAP3K13 | 0.45290760 |
| 132 | GRK7 | 0.44944889 |
| 133 | PRKG1 | 0.44887631 |
| 134 | MAP2K6 | 0.43327365 |
| 135 | PRKCA | 0.42708596 |
| 136 | CSF1R | 0.42634620 |
| 137 | CDC42BPA | 0.42464336 |
| 138 | NEK6 | 0.42379014 |
| 139 | PIK3CA | 0.41238763 |
| 140 | CAMK1D | 0.39413959 |
| 141 | LYN | 0.39033293 |
| 142 | ROCK2 | 0.38734562 |
| 143 | PKN1 | 0.38611410 |
| 144 | MET | 0.38068434 |
| 145 | PDPK1 | 0.37752085 |
| 146 | ACVR1B | 0.36988629 |
| 147 | PRKACA | 0.36652929 |
| 148 | IRAK2 | 0.36529083 |
| 149 | ABL2 | 0.36383210 |
| 150 | ERBB3 | 0.36110610 |
| 151 | MAP3K5 | 0.35643172 |
| 152 | SRC | 0.35369185 |
| 153 | TGFBR2 | 0.35222593 |
| 154 | DYRK1A | 0.34675510 |
| 155 | PRKD3 | 0.34642081 |
| 156 | RPS6KB1 | 0.34601611 |
| 157 | MAP2K1 | 0.34285483 |
| 158 | TRIB3 | 0.34176026 |
| 159 | JAK2 | 0.33714957 |
| 160 | TYRO3 | 0.33683058 |
| 161 | RPS6KA5 | 0.33589153 |
| 162 | JAK1 | 0.31868815 |
| 163 | GRK6 | 0.31829982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 4.33097808 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.06152689 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.73431746 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01875008 |
| 5 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.82352221 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67445626 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67166674 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.63098151 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.50557125 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38431567 |
| 11 | Gap junction_Homo sapiens_hsa04540 | 2.33401110 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.31090778 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29696268 |
| 14 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 2.27208870 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27079909 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25927315 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.14551628 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07503139 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00681059 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00548531 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00484465 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98417141 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.98207903 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93727407 |
| 25 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.92806009 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.91804367 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89320964 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88390497 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.81452495 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.80087736 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79728234 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78680723 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76868000 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75953342 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75274534 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.74969236 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.74385806 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.69631745 |
| 39 | Alcoholism_Homo sapiens_hsa05034 | 1.67018353 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64800143 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62866827 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.60152049 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.57847664 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55334205 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.51971379 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50549876 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39701413 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.39555679 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27453319 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26825013 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26402572 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23852741 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21192743 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20230377 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14540650 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13871264 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.13445880 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13437393 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13384526 |
| 60 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09845378 |
| 61 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.08118035 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03967132 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 1.01886029 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01428603 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01208255 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00015514 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.99591954 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98991248 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96995840 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96557923 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93924199 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.91730063 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.91057936 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90589996 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87821507 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85922041 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85885804 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85694407 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84760310 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82949902 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81854052 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80247902 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78443723 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76158948 |
| 85 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75644007 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73920244 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.73648214 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73594462 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72266190 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71240240 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70416480 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.69994600 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69768863 |
| 94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69390576 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66348838 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63610051 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61885863 |
| 98 | Adherens junction_Homo sapiens_hsa04520 | 0.61111575 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61071931 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60802518 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60723343 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60620864 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60037648 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.59500952 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.58622109 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57511120 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57008432 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56816251 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55296633 |
| 110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54729126 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52777859 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51890905 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51176404 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50432894 |
| 115 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49611535 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47868072 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46320074 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45198838 |
| 119 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44900297 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43737083 |
| 121 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43573155 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43424503 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42444593 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | 0.42350263 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41312062 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41175970 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40643656 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39691325 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39110512 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34949492 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34575106 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29477540 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27307070 |
| 134 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27081589 |
| 135 | Insulin secretion_Homo sapiens_hsa04911 | 0.24024943 |
| 136 | Mineral absorption_Homo sapiens_hsa04978 | 0.23758157 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22134308 |
| 138 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20308760 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20268289 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.19492153 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18870111 |
| 142 | Renin secretion_Homo sapiens_hsa04924 | 0.17953645 |
| 143 | Morphine addiction_Homo sapiens_hsa05032 | 0.17483566 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17389273 |
| 145 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.17080111 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15851526 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14110128 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.13753163 |
| 149 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13438458 |
| 150 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.12568066 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12071434 |
| 152 | Circadian rhythm_Homo sapiens_hsa04710 | 0.11630874 |
| 153 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.08053605 |
| 154 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07948103 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07312127 |
| 156 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07281180 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06708246 |
| 158 | Taste transduction_Homo sapiens_hsa04742 | 0.05549801 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04302017 |

